184 related articles for article (PubMed ID: 21733792)
1. [Mephedrone -- an old-new drug of abuse].
Tóth AR; Hideg Z; Institóris L
Orv Hetil; 2011 Jul; 152(30):1192-6. PubMed ID: 21733792
[TBL] [Abstract][Full Text] [Related]
2. Frequency and structure of stimulant designer drug consumption among suspected drug users in Budapest and South-East Hungary in 2012-2013.
Institóris L; Árok Z; Seprenyi K; Varga T; Sára-Klausz G; Keller É; Tóth RA; Sala L; Kereszty É; Róna K
Forensic Sci Int; 2015 Mar; 248():181-6. PubMed ID: 25671307
[TBL] [Abstract][Full Text] [Related]
3. Mephedrone (methylmethcathinone) in toxicology casework: a Northern Ireland perspective.
Cosbey SH; Peters KL; Quinn A; Bentley A
J Anal Toxicol; 2013 Mar; 37(2):74-82. PubMed ID: 23354334
[TBL] [Abstract][Full Text] [Related]
4. [The phenomenon of drug change in the interviews with injecting drug users].
Rácz J; Csák R; Faragó R; Vadász V
Psychiatr Hung; 2012; 27(1):29-47. PubMed ID: 22493147
[TBL] [Abstract][Full Text] [Related]
5. [Mephedrone].
Bertrand X; Gensburger M; Steckx E
Rev Med Liege; 2011 Oct; 66(10):540-4. PubMed ID: 22141261
[TBL] [Abstract][Full Text] [Related]
6. In vitro metabolism studies on mephedrone and analysis of forensic cases.
Pedersen AJ; Reitzel LA; Johansen SS; Linnet K
Drug Test Anal; 2013 Jun; 5(6):430-8. PubMed ID: 22573603
[TBL] [Abstract][Full Text] [Related]
7. The pharmacology and toxicology of the synthetic cathinone mephedrone (4-methylmethcathinone).
Dargan PI; Sedefov R; Gallegos A; Wood DM
Drug Test Anal; 2011; 3(7-8):454-63. PubMed ID: 21755604
[TBL] [Abstract][Full Text] [Related]
8. Changes in illicit, licit and stimulant designer drug use patterns in South-East Hungary between 2008 and 2015.
Árok Z; Csesztregi T; Sija É; Varga T; Kereszty ÉM; Tóth RA; Institóris L
Leg Med (Tokyo); 2017 Sep; 28():37-44. PubMed ID: 28759769
[TBL] [Abstract][Full Text] [Related]
9. [Mephedrone: a designer drug of recent use in France].
Debruyne D; Courné MA; Le Boisselier R; Djezzar S; Gérardin M; Boucher A; Karila L; Coquerel A; Mallaret M
Therapie; 2010; 65(6):519-24. PubMed ID: 21176758
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the stability of mephedrone in ante-mortem and post-mortem blood specimens.
Busardò FP; Kyriakou C; Tittarelli R; Mannocchi G; Pantano F; Santurro A; Zaami S; Baglìo G
Forensic Sci Int; 2015 Nov; 256():28-37. PubMed ID: 26295910
[TBL] [Abstract][Full Text] [Related]
11. Mephedrone use and associated adverse effects in school and college/university students before the UK legislation change.
Dargan PI; Albert S; Wood DM
QJM; 2010 Nov; 103(11):875-9. PubMed ID: 20675396
[TBL] [Abstract][Full Text] [Related]
12. 11 analytically confirmed cases of mexedrone use among polydrug users.
Roberts L; Ford L; Patel N; Vale JA; Bradberry SM
Clin Toxicol (Phila); 2017 Mar; 55(3):181-186. PubMed ID: 28075189
[TBL] [Abstract][Full Text] [Related]
13. [Mephedrone: a new synthetic drug].
Petit A; Karila L; Sananes M; Lejoyeux M
Presse Med; 2013 Oct; 42(10):1310-6. PubMed ID: 23669315
[TBL] [Abstract][Full Text] [Related]
14. Toxicological findings in a fatal multidrug intoxication involving mephedrone.
Gerace E; Petrarulo M; Bison F; Salomone A; Vincenti M
Forensic Sci Int; 2014 Oct; 243():68-73. PubMed ID: 24846124
[TBL] [Abstract][Full Text] [Related]
15. 'Heads held high': an exploratory study of legal highs in pre-legislation Ireland.
Van Hout MC; Brennan R
J Ethn Subst Abuse; 2011; 10(3):256-72. PubMed ID: 21888502
[TBL] [Abstract][Full Text] [Related]
16. Mass spectrometric evaluation of mephedrone in vivo human metabolism: identification of phase I and phase II metabolites, including a novel succinyl conjugate.
Pozo ÓJ; Ibáñez M; Sancho JV; Lahoz-Beneytez J; Farré M; Papaseit E; de la Torre R; Hernández F
Drug Metab Dispos; 2015 Feb; 43(2):248-57. PubMed ID: 25468950
[TBL] [Abstract][Full Text] [Related]
17. The role of illicit, licit, and designer drugs in the traffic in Hungary.
Institóris L; Hidvégi E; Dobos A; Sija É; Kereszty ÉM; Tajti LB; Somogyi GP; Varga T
Forensic Sci Int; 2017 Jun; 275():234-241. PubMed ID: 28412575
[TBL] [Abstract][Full Text] [Related]
18. Experiences with mephedrone pre- and post-legislative controls: perceptions of safety and sources of supply.
McElrath K; O'Neill C
Int J Drug Policy; 2011 Mar; 22(2):120-7. PubMed ID: 21242082
[TBL] [Abstract][Full Text] [Related]
19. Mephedrone, a new designer drug of abuse, produces acute hemodynamic effects in the rat.
Meng H; Cao J; Kang J; Ying X; Ji J; Reynolds W; Rampe D
Toxicol Lett; 2012 Jan; 208(1):62-8. PubMed ID: 22037396
[TBL] [Abstract][Full Text] [Related]
20. GHB and synthetic cathinones: clinical effects and potential consequences.
Karila L; Reynaud M
Drug Test Anal; 2011 Sep; 3(9):552-9. PubMed ID: 21960540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
